Ikarian Capital LLC 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:32 pm Sale |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Ikarian Capital LLC | 36,576 0.200% |
-1,027,385 (-96.56%) |
Filing |
| 2021-02-16 08:31 am Purchase |
2020-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Ikarian Capital LLC | 1,063,961 5.900% |
117,356 (+12.40%) |
Filing |